Changeflow GovPing Courts & Legal Eli Lilly v. Aios, Inc. - Civil Case
Routine Enforcement Added Final

Eli Lilly v. Aios, Inc. - Civil Case

Favicon for www.cand.uscourts.gov NDCA Recently Filed Documents
Filed
Detected
Email

Summary

Eli Lilly and Company filed a civil case against Aios, Inc. and Fella Medical Group entities on April 23, 2025, in the U.S. District Court for the Northern District of California. The case involves 'Other Statutory Actions' under federal question jurisdiction. Aios, Inc. filed a statement of recent decision on March 23, 2026.

What changed

This document pertains to a new civil case, Eli Lilly and Company v. Aios, Inc., filed on April 23, 2025, in the U.S. District Court for the Northern District of California. The case is categorized under 'Other Statutory Actions' and falls under federal question jurisdiction. The last filing noted is a 'STATEMENT OF RECENT DECISION' filed by Aios, Inc. on March 23, 2026.

As this is a new litigation filing, the immediate implication for compliance officers is the need to track potential legal developments that could impact intellectual property rights or business practices related to pharmaceutical products. No specific compliance actions or deadlines are indicated by this filing itself, but ongoing monitoring of the case docket is advised for any substantive rulings or settlements.

What to do next

  1. Monitor case docket for Eli Lilly v. Aios, Inc. (Case Number 4:25-cv-03535-HSG) for significant developments.

Archived snapshot

Mar 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Eli Lilly and Company v. Aios, Inc.

Case Number: 4:25-cv-03535-HSG Judge: Gilliam, Haywood S Location: Oakland Case Type: Civil Case Basis: Federal Question Nature of Suit: Other Statutory Actions Date Filed:

April 23, 2025

Last Filing Date:

March 23, 2026

View Publicly Available Documents Case Summary No summary of this case is available

Recent Filings

| Date Filed | Docket Number | Document Description |
| --- | --- | --- |
| 03-23-26 | 87 | STATEMENT OF RECENT DECISION pursuant to Civil Local Rule 7-3.d filed byAios, Inc., Fella Medical Group P.A., Fella Medical Group P.C.. (Attachments: # (1) Exhibit A)(Related document(s)[58]) (James, Lea) |
Return to top

Get daily alerts for NDCA Recently Filed Documents

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from N.D. California.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
N.D. California
Filed
April 23rd, 2025
Instrument
Enforcement
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
4:25-cv-03535-HSG
Docket
4:25-cv-03535-HSG

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Litigation
Geographic scope
California US-CA

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Litigation

Get alerts for this source

We'll email you when NDCA Recently Filed Documents publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!